RxDoctor Payments DataLook up a doctor →

Ronald Villanueva, MD

Endocrinology, Diabetes & Metabolism · Lakewood, NJNPI 1508838434

Payments from drug & device makers

$217,003in general payments, 2019–2025

Across 1,611 payments — averaging $134.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$105K
  • Lilly USA, LLC$43K
  • Sanofi-aventis U.S. LLC$32K
  • Boehringer Ingelheim$15K
  • AbbVie$5K
  • Novo Nordisk$4K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)267$105,235
Lilly USA, LLC207$43,477
Sanofi-aventis U.S. LLC92$32,259
Boehringer Ingelheim64$14,690
AbbVie36$5,499
Novo Nordisk267$3,586
Amneal Pharmaceuticals LLC89$1,494
Dexcom, Inc.67$1,259
Medtronic(2 entities)29$873
Corcept Therapeutics53$830
Abbott41$807
Bayer37$691
Ascensia Diabetes Care US Inc.34$549
Tandem Diabetes Care, Inc.19$538
Mannkind Corporation34$525
Chiesi USA, Inc.8$446
Amgen(2 entities)27$443
Intuity Medical Inc39$422
Insulet Corporation20$359
Pfizer15$265
Antares Pharma, Inc.14$252
Xeris Pharmaceuticals, Inc.15$238
Radius Health, Inc.12$197
Madrigal Pharmaceuticals8$164
OPKO Pharmaceuticals, LLC11$164
Cequr Corporation3$147
Merck10$130
Esperion Therapeutics, Inc.8$128
Kowa Pharmaceuticals America, Inc.9$128
IBSA Pharma Inc.7$99
Amarin Pharma, Inc.7$94
Ascendis Pharma Endocrinology Inc4$72
Sanofi1$71
Verity Pharmaceuticals Inc.4$67
Eisai Inc.5$64
Kyowa Kirin, Inc.4$63
Clarus Therapeutics Inc.4$57
BD4$56
Vivus LLC4$56
Novartis3$54
Johnson & Johnson3$46
Aytu Biopharma, Inc.3$39
Recordati_rare_diseases_inc.2$34
BETA Bionics, Inc.1$26
Lifescan, Inc.2$24
Currax Pharmaceuticals LLC2$24
RGH Enterprises LLC1$23
Halozyme Inc1$22
Sequel Med Tech, LLC1$21
Soleno Therapeutics, Inc.1$18
Nalpropion Pharmaceuticals LLC1$17
Amryt Pharma Holdings Ltd1$17
Companion Medical, Inc.1$17
Intra-sana Laboratories1$16
Rhythm Pharmaceuticals, Inc.1$15
Valeritas, Inc.1$15
Endo Pharmaceuticals Inc.1$15
Almatica Pharma LLC1$14
Ultragenyx Pharmaceutical Inc.1$14
Acella Pharmaceuticals, LLC1$13

How this compares

$217,003 in reported general payments places this provider in the 95th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.

See all endocrinology, diabetes & metabolism providers in New Jersey →

Medicare billing

Part B allowed, 2024
$611,789
Medicare patients
1,182
Services billed
6,245

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Lakewood

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →